Bausch & Lomb, which is owned by private-equity firm Warburg Pincus, is nearing a deal to sell itself to generic-drug maker Valeant for about $9 billion.
Sergio Marchionne is trying to pull off the deal of his lifetime, and there are lots of pieces to go around for bankers, lawyers and other cogs in the Wall Street deal machine.
Recent Comments